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https://doi.org/10.1186/s12913-020-05717-1RESEARCH ARTICLE Open AccessRepresentativeness of personality and
involvement preferences in a web-based
survey on healthcare decision-making
Søren Birkeland1* , Thea Linkhorst1, Anders Haakonsson1, Michael John Barry2 and Sören Möller1Abstract
Background: Obtaining a sample that is representative of the group of interest is of utmost importance in
questionnaire studies. In a survey using a state authorized web-portal for citizen communication with authorities,
we wanted to investigate the view of adult men on patient involvement in health care decision-making regarding
Prostate-Specific Antigen test for prostatic cancer. In this paper, we report on sample characteristics and
representativeness of our sample in terms of personality and baseline involvement preferences.
Methods: We compared personality profiles (BFI-10) and baseline healthcare decision-making preferences (CPS) in
our sample (n = 6756) to internationally available datasets. Pooled data from a) US, UK, Canada, Australia, and New
Zealand (n = 1512), b) Germany, Netherlands, Switzerland, and Belgium (n = 1136), and c) Norway, Sweden, Finland,
and Denmark (n = 1313) were used for BFI-10 comparisons. Regarding CPS, we compared our sample with three
previous datasets relating to decision-making in cancer (n = 425, 387, and 199).
Results: Although statistically significant differences particularly appeared in large dataset comparisons, sample BFI-
10 and CPS profiles mostly were within the range of those previously reported. Similarity was greatest in BFI-10
comparisons with group a) where no statistically significant difference could be established in factors
‘agreeableness’ and ‘neuroticism’ (p = .095 and .578, respectively).
Conclusion: Despite some variation, our sample displays personality and baseline preference profiles that are
generally similar to those described in previous international studies. For example, this was the case with the BFI-10
‘agreeableness’ measure (incl. trust and fault-finding items), an important factor in healthcare decision-making.
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Communicating with patients plays an important role in
health care. In this regard, since patients must bear the
consequences of health care decisions, a mandatory role
for patients is increasingly being recommended [1, 2].
Research has suggested that problematic communication
and poorly delivered information is often a major reason
when patients decide to initiate a malpractice action [3, 4].
Nonetheless, we still have little knowledge about whether
greater patient involvement in health care decision-
making improves satisfaction and reduces a patient’s
likelihood to initiate a malpractice complaint [2, 5].
In order to study these potential relationships, we
conducted a large national survey with hypothetical vi-
gnettes illustrating various levels of patient participation
in decision-making together with different outcomes.
Development of the survey, its core structure, and exam-
ples of survey elements have been previously described
[2]. Following completion of the survey, sample repre-
sentativeness came into question [6, 7]. The representa-
tiveness of a sample can be defined in terms of its
external validity in relation to the target population the
sample is meant to represent, thereby allowing survey
findings to generalize to the population of interest [8]. A
poor coverage of the obtained sample may substantially
bias survey findings which may severely affect their
external validity [7, 8]. We previously reported on the
representativeness of our sample in terms of age and
socio-demographic characteristics [7]. As have others,
we found the response rate (RR) to be higher in older
men and in men living in rural areas while RRs were
lower in higher income areas [7]. However, RRs may also
depend on other aspects. Research has suggested that
personality could be an important factor in the decision
to take part in surveys [9]. At the same time, preferences
for involvement in decision-making, which was the sub-
ject of our survey, could be hypothesized to be different
among personality types [10–13] making a lack of repre-
sentativeness of our sample particularly problematic.
Thus, in addition to comparing respondents and non-
respondents with respect to basic sociodemographic char-
acteristics [8, 14, 15] it seems reasonable to consider also
sample representativeness in regard to personality charac-
teristics and baseline preferences [7]. In this paper, through
comparison with previously reported figures, we report on
the representativeness of our survey sample in terms of
personality and baseline preference characteristics.
Methods
Setting and measures
Our survey illustrated various levels of patient involve-
ment in healthcare decision-making through use of
multiple versions of a case vignette [2]. We randomized
participants into vignette versions and accompanyingquestions and measured their imagined satisfaction with
the healthcare illustrated and participants’ desire to
complain. The survey used Prostate-Specific Antigen
(PSA) test for early prostate cancer (PCa) detection as a
model for studying preferences for participation, as risks
and benefits are delicately balanced and a choice for or
against having the test may have far-reaching conse-
quences. Based on existing recommendations regarding
PSA testing, we chose men in the age span of 45–70
years [1, 16]. Measures comprised purpose-designed
questions (e.g. socio-demographic characteristics) and
standardized validated instruments, including personality
measurement. We also aimed to achieve a ‘standardized’
baseline measure of participants’ preferences for involve-
ment in healthcare decision-making holding everything
else equal (meaning type of decision, the health care
provider in question, etc.). Regarding participant person-
ality, we used the BFI-10 (Big Five Inventory – 10) tool
that has been previously used to investigate personality
in studies of decision-making regarding PCa [17]. BFI-10
is a validated 10-item personality instrument that mea-
sures the Big Five personality dimensions Extraversion,
Agreeableness, Conscientiousness, Emotional Stability,
and Openness [18]. It was developed from the 44-item
Big Five Inventory and designed for use in contexts with
limited time available [18, 19]. We used the ‘Control
Preferences Scale’ (CPS) for measuring baseline prefer-
ences for involvement in healthcare decision-making
[20, 21]. The CPS is a validated instrument that has been
previously used in studies on decision-making about
cancer care [20]. Respondents are requested to mark one
statement among five to describe the degree of control
the respondent wants when health care decisions are
made: A. “I prefer to make the final selection about
which treatment I will receive,” B. “I prefer to make the
final selection of my treatment after seriously considering
my doctor’s opinion,” C. “I prefer that my doctor and I
share responsibility for deciding which treatment is best
for me,” D. “I prefer that my doctor makes the final deci-
sion about which treatment, but seriously considers my
opinion,” or E. “I prefer to leave all decisions regarding
treatment to my doctor” [21]. Through patient and pub-
lic involvement in designing and fine-tuning the survey,
we aimed to enhance survey acceptability and RRs in the
invited population [2].
Procedures
We used REDCap® for the survey and made invitations
through the Danish authorities’ ‘digital mailbox’ that is a
state authorized web platform for safe communication
between citizens and the authorities. With due consider-
ation to respecting people’s right to not participate in
our survey, we chose to send out only one reminder
after 14 days. In total, 6756 responded out of a sample of
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by the Danish Health Data Authority amounting to a RR
rate of 30 % [7]. We analyzed representativeness of the
sample through comparisons of BFI-10 and CPS profiles
of our respondents with BFI-10 and CPS figures
reported in previous studies. Regarding BFI-10, we used
survey data from the International Social Survey
Program (ISSP, 2005) that includes BFI-10 data from
different countries [22]. Data were retrieved from the
Gesis database where open science collected data are
made available to the scientific community (Gesis;
Leibniz Institute for the Social Sciences) [23]. Research
has previously suggested that personality profiles may
vary among cultures and language areas [24]. Similarly,
preferences for involvement in health care decision-
making may differ among countries [25]. By way of
example, findings from a study found differences
between the views on patient involvement between
United Kingdom and Sweden [26]. For comparisons, we
selected 3 groups based on data from a) An ‘Anglo-
phone’ group: US, United Kingdom, Canada, Australia,
and New Zealand (US/UK/CA/AU/NZ); b) A ‘European-
West Germanic group’: Germany, the Netherlands,
Switzerland, and Belgium-Flemish Region (DE/NL/CH/
BE-FL); and c) A ‘European-Scandinavian group’: Norway,
Sweden, Finland, and (previous) Danish data (NO/SE/FI/
DK). The aim of these choices was to both compare with
countries assumed to be quite similar to Denmark, but on
the other hand also to compare to large Western countries,
to enable discussion of the external validity of our results
outside Scandinavia as well. For control preference compar-
isons, repeated searches on PubMED revealed that scarce
research data exist regarding CPS profiles in non-patient
populations. We therefore used data from previously






Age (mean, SD) 59.1 (7.3) 56.5 (
P-value < 0.00
Marital status
Living together 5370 (79.5%) 1170(
Single or partner, not living together 1386 (20.5%) 308 (
P-value 0.78
Affiliation with labor market
Student/ … 11 (0.2%) 3 (0.2
Working/ … 4445 (65.8%) 1043
Unemployed/Retired 2300 (34.0%) 456 (
P-value 0.023
*) Missing: 34 (marital status), 10 (affiliation with labor market), **)Missing: 19 (marit
(affiliation with labor market)perspective. We chose comparison data sets from studies,
available from any one of the countries mentioned above
(groups a, b, and c) from 2005 and onwards, and preferably
concerning men and PCa. Three studies met the require-
ments [27–29].Statistics
To study representativeness, we compared our sample
with the reference samples by reporting counts and
proportions of each answer category, and testing distri-
butions by chi-squared tests, respectively, or Fisher’s
exact test in case of cell counts below five. We report
numerical age with means and standard deviations
compared by Wilcoxon rank sum tests. Stata version 16
(Stata-Corp, LP, College Station, TX) was used for the
analysis and p-values below 0.05 were considered statis-
tically significant.Results
Comparisons of personality characteristics in sample and
previous datasets
Table 1 compares the sociodemographic characteris-
tics of our sample to group a-c. Bearing in mind the
relatively large sample sizes, we established a statisti-
cally significant difference between socio-demographic
characteristics of our survey sample and group a-c
datasets used for comparison. More importantly, however,
despite a slightly higher mean age of our sample, the char-
acteristics of our sample fell within the range of the other
aggregated data sets, as our estimates lie between those of
the lowest and highest comparison groups. Besides,
sample characteristics (marital status and working status
compositions) bore closest resemblance to data from





(n = 1136) (**)
Group c NO/SE/FI/DK
(n = 1313) (***)
7.3) 56.7 (7.4) 56.1 (6.9)
01 < 0.0001 < 0.0001
79.2%) 934 (83.6%) 1091 (85.0%)
20.8%) 183 (16.4%) 193 (15.1%)
0.0014 < 0.0001
%) 0 5 (0.4%)
(69.4%) 677 (60.6%) 908 (71.8%)
31.4%) 440 (39.4%) 352 (27.9%)
0.0013 < 0.0001
al status), 19 (affiliation with labor market), ***)Missing: 29 (marital status), 48
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our sample in terms of the BFI-10 measure to the
personality characteristics of group a-c. For distinct item
ratings, please refer to Additional file 1. BFI factor
‘Agreeableness’ is determined from items 2 and 7
(reversed) while factor ‘Conscientiousness’ is derived
from item 3 (reversed) and item 8. ‘Extraversion’ is de-
termined from item 1 (reversed) and item 5, ‘Neuroticism’
is determined from item 4 (reversed) and item 9, and
‘Openness’ is determined from item 5 (reversed) and item
10 [18].
For three (and four for group c) out of five personality
factors, there were significant differences between the
study sample and the general population groups. How-
ever, factor mean scores of our sample fell within the
range of group a-c in three out of five BFI factors. Again,
if anything, the profile scores of our sample mostly
resembled the profile of comparison group a (English
speaking countries).Comparisons of baseline control preferences in sample
and previous studies
Table 3 shows control preferences in the sample as well as
comparisons made with CPS figures published in previous
studies [27–29]. In concordance with the presentation of
data in the studies compared to, we collapsed the original






Agreeableness 4.68 (1.22) 4.61 (1.33)
Conscientiousness 4.18 (1.33) 3.49 (1.23)
Extraversion 4.71 (1.68) 5.62 (1.68)
Neuroticism 7.32 (1.59) 7.36 (1.67)
Openness 6.13 (1.65) 5.24 (1.33)
How well do the following statements describe your personality?
- is reserved (1) 3.51 (1.04) 2.67 (1.10)
- is generally trusting (2) 2.01 (0.66) 1.91 (0.76)
-tends to be lazy (3) 3.86 (0.95) 4.13 (0.94)
-is relaxed, handles stress well (4) 2.32 (0.89) 2.30 (0.97)
-has few artistic interests (5) 2.96 (1.15) 2.77 (1.15)
-is outgoing, sociable (6) 2.22 (0.93) 2.28 (0.98)
-tends to find fault with others (7) 3.33 (0.94) 3.31 (0.98)
-does a thorough job (8) 2.04 (0.71) 1.62 (0.58)
-gets nervous easily (9) 3.63 (0.97) 3.65 (1.06)
-has an active imagination (10) 3.10 (1.09) 2.00 (0.85)role’, ‘collaborative role’, and ‘passive role’). Regarding the
CPS profile of our sample, it mostly fell within the range
of previously reported profiles.
Discussion
Using a state authorized web-based platform to distrib-
ute survey invitations provides an opportunity to rapidly
get access to great numbers of potential respondents
while reducing research costs [6]. The approach, how-
ever, can be challenged by issues relating to achieving a
representative sample. In the invitation letter for our
survey using the so-called digital mailbox, men were
encouraged to participate to acquire knowledge about
health care users’ preferences regarding participation in
decisions about the medical care they receive. Unfortu-
nately, however, only a minority chose to utilize this
opportunity to have their voice heard, raising the
question whether those who decided to respond are rep-
resentative of our target population. Uneven representa-
tion of groups with different opinions regarding patient
involvement could potentially introduce a significant
non-responder bias requiring statistical adjustment be
considered. We therefore previously reported on the
representativeness of our sample in terms of socio-
demographic characteristics and overall found our
sample to fairly well represent the population of Danish
adult men [7]. However, RRs were statistically signifi-








0.095 4.80 (1.41) 0.040 4.43 (1.47) 0.006
< 0.001 3.57 (1.25) < 0.001 3.26 (1.43) < 0.001
< 0.001 5.23 (1.57) < 0.001 4.41 (1.99) < 0.001
0.578 7.24 (1.58) 0.008 7.94 (1.87) < 0.001
< 0.001 5.67 (1.30) < 0.001 5.72 (1.40) < 0.001
< 0.001 2.94 (1.09) < 0.001 3.74 (1.27) < 0.001
< 0.001 2.30 (0.93) < 0.001 1.73 (0.80) < 0.001
< 0.001 4.07 (0.98) < 0.001 4.15 (1.19) < 0.001
0.472 2.41 (0.94) < 0.001 2.11 (1.03) < 0.001
< 0.001 2.64 (1.16) < 0.001 2.26 (1.28) < 0.001
0.077 2.17 (0.85) 0.574 2.15 (1.06) 0.034
0.651 3.50 (0.95) < 0.001 3.29 (1.18) 0.407
< 0.001 1.64 (0.60) < 0.001 1.40 (0.61) < 0.001
0.345 3.65 (0.99) 0.884 4.06 (1.19) < 0.001
< 0.001 2.32 (0.92) < 0.001 1.95 (0.93) < 0.001
Table 3 CPS characteristics in sample and comparison with previous studies
CPS Sample (%) Hack [27] Noguera [28] Yennurajalingam et al. [29]
Year 2019 2007 2014 2018
Sample size 6756 425 387 199









Age 59 (mean) 67 (mean) 58 (mean) 56 (median)
1 & 2 total (‘Active role’) 34.9% (2358) 30.6 (130) 31.2% (119) 43.2% (86)
3 (‘Collaborative role’) 41.6% (2810) 49.2 (209) 47.6% (182) 41.2% (82)
4 & 5 total (‘Passive role’) 23.5% (1588) 20.2 (86) 21.2% (81) 16.6% (33)
P-value 0.009 0.066 0.021
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[7]. We finally concluded that our socio-demographic com-
parisons needed to be supplemented with studies of the
representativeness regarding personality characteristics and
respondents’ general view regarding patient involvement. In
this paper, we compared the personality and control prefer-
ence characteristics of our sample to previously collected
international datasets. Despite minor variations, we found
our sample to chiefly resemble international data. Below,
we discuss findings in the context of the research literature.
Sample personality characteristics
On three scales (agreeableness, extraversion, and neur-
oticism scales) out of five, rating estimates were within
the range of our comparison groups (a-c). Regarding
item ratings, our estimates fell within the range of com-
parison group averages in five items (reserved, trusting,
relaxed, outgoing, fault finding) out of ten. Another five
item profiles of our sample, especially relating to
‘Conscientiousness’ and ‘Openness’ scales, fell outside
previously published figures. At least in part, our data
may reflect the fact that population personality figures
may not be constant over time and may have changed
since ISSP data collections from 2005 [30]. It has been
noted that the stability implied by the notion of ‘person-
ality’ pertains to an individual life span and therefore
does not preclude generational changes in personality
trait distributions [30]. Correspondingly, previous cohort
studies agreed that, e.g., ‘Conscientiousness’ ratings seem
to increase over time [30, 31]. In spite of everything, the
rating estimates in our sample mostly resembled those
of the English-speaking countries rather than e.g. the
Scandinavian countries group as a whole. The reason for
this apparently greater similarity with English speaking
countries remains unclear. It might reflect a greater
similarity with English speaking countries but could
also result from variation in the design of surveys
and samples included in the Gesis data repository. Inthis regard, our comparisons in Table 1 suggest that
sample compositions in terms of socio-demographic
characteristics differ amongst groups and that sample
differences may be smallest between our sample and
the group of English speaking countries. In other
words, regarding the personality and decision prefer-
ence measures under study, our sample seems more
similar to samples from English speaking countries
than to, e.g., previously reported Scandinavian sam-
ples. Among others, similarities were clear regarding
the trust item (and associated ‘agreeableness’ factor)
that may be a particularly important aspect of per-
sonality, when considering healthcare communication
and decision-making [32]. Physicians’ communication
has an important impact on patients’ trust and trust
generally is a crucial element of the healthcare
provider-patient relationship. Correspondingly, trust
may be particularly important when patients are in
an exposed situation and, e.g., confront a potentially
life-threatening illness such as cancer and therefore
need to rely strongly on their care providers [33–35].
Control preferences
Regarding control preference profiles, our sample not
only displays a distribution that pretty nicely reflects the
(‘bell’) distribution that has been repeatedly reported in
the literature [36–38], but also specifically resemble CPS
profiles reported in studies on men’s’ preferences for in-
volvement in cancer care decisions. In this regard, it is
remarkable that, if comparing to Degner and Sloan’s 27
year old data from the ‘pre-patient-involvement-era’, it
appears that control preference figures have generally
changed in favor of a more collaborative or active role
[38, 39]. Still, it must be remembered that most other
studies have been conducted in patient samples. As
such, Degner and Sloan’s original study is among the
few studies including also non-patients [20]. On the
other hand, it probably could be claimed that similarity
Birkeland et al. BMC Health Services Research          (2020) 20:851 Page 6 of 8of our sample CPS figures with the control preferences
of real life patients would be of great importance. Hence,
it seems as if the preferences for involvement in
decision-making of our sample is rather similar to
patient preferences found in real life settings [27–29].
Consideration regarding limitations and strengths
This leads to considering limitations and strengths of
our study in more detail. It would be undesirable to
conclude from a survey with a 30 % response rate that
the population generally wants to participate in health
care decision making if those 70 % of the population
not wanting to participate in the survey are people who
would generally abstain from any participation in health
care decision making [7, 40]. Similarly, ‘norm data’ may
not necessarily always be representative of the relevant
population. For example, to the authors’ knowledge, it
remains unclear to what extent, e.g., ISSP 2005 datasets
were representative themselves of the countries studied.
Findings from previous research suggested that study
participation may itself depend on personality factors
[41, 42]. For example, students in a survey were found
to be more likely to be socially engaged (‘investigative’)
personality types while they were less likely to be ‘en-
terprising’ or ‘artistic’ types [43]. In this regard, Holland
personality typology was used with ‘enterprising’ or
‘artistic’ types partially correlating with Big Five’s extra-
version and openness factors [9, 43]. In other words,
individuals who score high on extroversion and open-
ness seem less willing to participate in research studies
[9, 41]. On the other hand, for example openness may
be related to a lower probability of quitting a survey
following recruitment and the relationship between
personality and survey participation thus may not be
that clear [42]. Correspondingly, little is known about
the association between decision-making preferences
and survey participation, and it is still possible that
those not participating in our survey may have dissimi-
lar personalities and control preferences. This hardly
can be ruled out without just comparing to responders
in another survey. Hence, strictly speaking, we have
demonstrated that to a considerable extent, our sample
seems comparable to international survey samples and
that it is therefore likely that our forthcoming survey
findings regarding preferences for participation in
decision-making can be replicated abroad. Specifically
regarding our comparison groups, as we found no com-
monly accepted categories in which culturally the BFI
scores are distinctly different, we chose to group coun-
tries on our own although with reference to some rela-
tively well known ‘categories’ (Western world English
speaking countries, Scandinavia, and European West
Germanic area). The latter categorization also explains
the specific selection of countries.Conclusion
Achieving reasonable representativeness of the popula-
tion under study in survey research is highly desirable to
allow for drawing inferences from survey findings. Fol-
lowing a survey on men’s view on patient involvement in
health care decision-making, we wanted to establish our
sample’s representativeness. With particular focus on
personality and baseline involvement preferences, we
studied whether those who responded rated similarly to
those participating in previous surveys. Despite some
variation, we found our sample to very well resemble
pre-existing international data which is important when
interpreting findings from further analyses of our survey
responses and making generalizations to an international
context.
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